A post-authorisation safety study (PASS) to evaluate cardiovascular events in adult patients with obstructive sleep apnoea (OSA) treated with solriamfetol (JZP865-401) First published 05/09/2022 Last updated 22/07/2024 EU PAS number:EUPAS45651 Study Planned